Qaderi K, Shahmoradi A, Thyagarajan A, Sahu R
Mil Med Res. 2025; 12(1):10.
PMID: 40033370
PMC: 11877967.
DOI: 10.1186/s40779-025-00597-0.
Kang Y, Kang Y, Zhang D, Yao J
Front Immunol. 2024; 15:1460533.
PMID: 39691714
PMC: 11649635.
DOI: 10.3389/fimmu.2024.1460533.
Vangala V, Chen Y, Dinavahi S, Gowda K, Lone N, Herlyn M
ACS Pharmacol Transl Sci. 2024; 7(11):3573-3584.
PMID: 39539277
PMC: 11555517.
DOI: 10.1021/acsptsci.4c00453.
Shi Y, An K, ShaoX Zhou , Zhang X, Kan Q, Tian X
Heliyon. 2024; 10(21):e38662.
PMID: 39524750
PMC: 11547969.
DOI: 10.1016/j.heliyon.2024.e38662.
Nguyen M, Nguyen T, Le T, Le T, Chau N, Le T
Heliyon. 2024; 10(20):e39229.
PMID: 39492898
PMC: 11530815.
DOI: 10.1016/j.heliyon.2024.e39229.
A Multi-Omics Prognostic Model Capturing Tumor Stemness and the Immune Microenvironment in Clear Cell Renal Cell Carcinoma.
Xiong B, Liu W, Liu Y, Chen T, Lin A, Song J
Biomedicines. 2024; 12(10).
PMID: 39457484
PMC: 11504857.
DOI: 10.3390/biomedicines12102171.
Stemness in solid malignancies: coping with immune attack.
Agudo J, Miao Y
Nat Rev Cancer. 2024; 25(1):27-40.
PMID: 39455862
DOI: 10.1038/s41568-024-00760-0.
Onco-Ontogeny of Squamous Cell Cancer of the First Pharyngeal Arch Derivatives.
Sat-Munoz D, Balderas-Pena L, Gomez-Sanchez E, Martinez-Herrera B, Trujillo-Hernandez B, Quiroga-Morales L
Int J Mol Sci. 2024; 25(18).
PMID: 39337467
PMC: 11432412.
DOI: 10.3390/ijms25189979.
Cancer Stem Cells in Oral Squamous Cell Carcinoma: A Narrative Review on Experimental Characteristics and Methodological Challenges.
Acharya S, Shai S, Choon Y, Gunardi I, Hartanto F, Kadir K
Biomedicines. 2024; 12(9).
PMID: 39335624
PMC: 11429394.
DOI: 10.3390/biomedicines12092111.
Trapped in Cells: A Selective Accumulation Approach for Type-I Photodynamic Ablation of Cancer Stem-like Cells.
Kim J, Lee J, Lee K, Xiong H, Li M, Kim J
JACS Au. 2024; 4(9):3657-3667.
PMID: 39328753
PMC: 11423316.
DOI: 10.1021/jacsau.4c00642.
SIX4 Activation in Inflammatory Response Drives the Transformation of Colorectal Epithelium into Inflammation and Tumor via Feedback-Enhancing Inflammatory Signaling to Induce Tumor Stemness Signaling.
Zhang Z, Huang H, Peng L, Zhou B, Yang H, Tang Z
Int J Biol Sci. 2024; 20(12):4618-4634.
PMID: 39309424
PMC: 11414381.
DOI: 10.7150/ijbs.93411.
Comparison of methods for cancer stem cell detection in prognosis of early stages NSCLC.
Chandouri B, Naves T, Yassine M, Ikhlef L, Tricard J, Chaunavel A
Br J Cancer. 2024; 131(9):1425-1436.
PMID: 39304747
PMC: 11519646.
DOI: 10.1038/s41416-024-02839-9.
Research progress on m6A demethylase FTO and its role in gynecological tumors.
Wang S, Liu Q
Front Oncol. 2024; 14:1413505.
PMID: 39175477
PMC: 11338917.
DOI: 10.3389/fonc.2024.1413505.
Competing endogenous RNAs regulatory crosstalk networks: The messages from the RNA world to signaling pathways directing cancer stem cell development.
Aria H, Azizi M, Nazem S, Mansoori B, Darbeheshti F, Niazmand A
Heliyon. 2024; 10(15):e35208.
PMID: 39170516
PMC: 11337742.
DOI: 10.1016/j.heliyon.2024.e35208.
Tumor Cell Stemness and Stromal Cell Features Contribute to Oral Cancer Outcome Disparity in Black Americans.
Mirshahidi S, Yuan I, Chen Z, Simental A, Lee S, Andrade Filho P
Cancers (Basel). 2024; 16(15).
PMID: 39123459
PMC: 11311411.
DOI: 10.3390/cancers16152730.
Forces Bless You: Mechanosensitive Piezo Channels in Gastrointestinal Physiology and Pathology.
Guo J, Li L, Chen F, Fu M, Cheng C, Wang M
Biomolecules. 2024; 14(7).
PMID: 39062518
PMC: 11274378.
DOI: 10.3390/biom14070804.
LINC00662 Promotes Aggressive Traits by Modulating OCT4 Expression through miR-335-5p in Gallbladder Cancer Cells.
Perez-Moreno P, Riquelme I, Bizama C, Vergara-Gomez L, Tapia J, Brebi P
Int J Mol Sci. 2024; 25(12).
PMID: 38928444
PMC: 11204134.
DOI: 10.3390/ijms25126740.
SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1-Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC.
Deng Q, Qiang J, Liu C, Ding J, Tu J, He X
Adv Sci (Weinh). 2024; 11(29):e2306860.
PMID: 38864559
PMC: 11304230.
DOI: 10.1002/advs.202306860.
Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients.
Zhang M, Zhang J, Liang X, Zhang M
BMC Med Genomics. 2024; 17(1):150.
PMID: 38822402
PMC: 11141027.
DOI: 10.1186/s12920-024-01920-9.
Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells.
Lin Y, Ku C, Wuputra K, Liu C, Wu D, Satou M
Int J Mol Sci. 2024; 25(10).
PMID: 38791215
PMC: 11120835.
DOI: 10.3390/ijms25105177.